In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …

Coronary artery in-stent restenosis (ISR) is driven by neointimal hyperplasia and
neoatherosclerosis in previously placed stents. Drug eluting stents (DES) have been …

Coronary artery calcification is prevalent in coronary heart disease with its progression
being predictive of future adverse cardiac events. Its presence is considered to be a marker …

Stent failure remains the major drawback to the use of coronary stents as a revascularization
strategy. Recent advances in imaging have substantially improved our understanding of the …

Coronary stenting or percutaneous coronary intervention (PCI) is widely used to treat
coronary artery disease. Improper deployment of stents may lead to post-PCI complication …

Intracoronary stent restenosis (ISR) is a clinically relevant challenge in the modern era.
Heterogeneity in patient-and lesion-specific factors can further compound this clinical …

Background This study aimed to report outcomes of intracoronary brachytherapy (ICBT) in
treating drug-eluting stent (DES) in-stent restenosis (ISR) and identify correlated factors …

In-stent restenosis (ISR) remains the predominant cause of stent failure and the most
common indication for repeat revascularization. Despite technological advances in stent …

Abstract Purpose of Review The catheter-based coronary intervention has become a well-
established therapeutic modality for obstructive coronary artery disease. However, in-stent …

There is a paucity of data on the contemporary use of non–drug-eluting devices (balloon
angioplasty or bare-metal stents) in contemporary percutaneous coronary intervention (PCI) …